BlogCOVID-19 and Sepsis: Risk-Stratifying Patients Based on Their Immune ResponseTimothy E. Sweeney, MD, PhD | February 26, 2021 Host-response diagnostics that “read” the immune response can help clinicians make better, faster treatment decisions
RegulatoryIVDR—The Impact of COVID-19Sherri Fraser, PhD | February 26, 2021 Industry concerns about IVDR implementation timelines
NewsReal-World Effectiveness of COVID-19 VaccineClalit Research Institute | February 25, 2021 First peer-reviewed real-world study of COVID-19 vaccine examined 600,000 vaccinated individuals
NewsLandmark Study Details New Human Reference GenomesUniversity of Maryland School of Medicine | February 25, 2021 The study provides new insights into the structure, variation, and mutation of the human genome
Industry NewsNew Robotic System for Ultra-High Throughput SARS-CoV-2 TestingZiath | February 24, 2021 A pioneering automated test robot, called STRIP-1, can process up to 20,000 SARS-CoV-2 samples in 24 hours
NewsPeople with SARS-CoV-2 Antibodies May Be Protected against ReinfectionNational Cancer Institute, National Institutes of Health | February 24, 2021 The new findings may explain why reinfection with the novel coronavirus appears to be relatively rare
NewsA New Way to Prevent and Treat Endometrial Cancer RecurrenceYale University | February 24, 2021 Researchers demonstrate sex hormones and insulin growth factors are associated with recurrence of endometrial cancer
March 24, 2021Practical Ways to Motivate Lab StaffClinical Lab Manager | February 23, 2021 Join Clinical Lab Manager as we present tips and solutions to keep your staff motivated
NewsNew Insights on How Interleukin-33 Contributes to Skin and Pancreatic CancersMassachusetts General Hospital | February 23, 2021 The results suggest that inhibiting IL-33 in cancer-prone cells may help prevent cancers associated with inflammation
NewsNew CRISPR-Based Gene Editing Tool Makes Sequential Genome EditsUniversity of Illinois at Chicago | February 23, 2021 With the new gene editing technique, researchers can program sequential genome edits over time